Unmasking Hypercoagulability: Superior Sagittal Sinus Thrombosis Attributed to Pernicious Anemia in a Patient With Normal Hemoglobin Levels

揭示高凝状态:正常血红蛋白水平患者因恶性贫血导致上矢状窦血栓形成

阅读:3

Abstract

BACKGROUND Superior sagittal sinus thrombosis is an uncommon but serious cerebrovascular disorder, often linked to a hypercoagulable state. One less common etiology of hypercoagulability is elevated homocysteine levels due to vitamin B12 deficiency caused by pernicious anemia, a process that usually also results in concurrent megaloblastic anemia. We describe a patient who developed superior sagittal sinus thrombosis despite normal hemoglobin and hematocrit values. CASE REPORT A 52-year-old man presented to the emergency department with first-time tonic-clonic seizure. Brain magnetic resonance imaging revealed thrombosis of the superior posterior segment of the superior sagittal sinus. Additional studies demonstrated deep vein thrombosis in the right peroneal vein. Extensive evaluation for potential prothrombotic causes revealed an elevated homocysteine level and vitamin B12 deficiency. The patient had serologic evidence of pernicious anemia; antibodies against intrinsic factor and gastric parietal cells were present. Despite the pernicious anemia diagnosis, his hemoglobin level was normal. High-dose oral vitamin B12 was administered to correct the deficiency and alleviate the hypercoagulable state. The patient was initially anticoagulated with a heparin infusion to treat the superior sagittal sinus thrombosis; therefore, intramuscular injections of vitamin B12 were avoided during hospitalization. He was ultimately discharged home with prescriptions for apixaban and intramuscular injections of vitamin B12. CONCLUSIONS Patients presenting with thrombotic events should be thoroughly evaluated for an underlying hypercoagulable state to ensure appropriate treatment and prevent complications. This case highlights the importance of considering hyperhomocysteinemia induced by vitamin B12 deficiency as a cause of thrombosis, even in patients with normal hemoglobin levels.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。